{
  "nctId": "NCT04688996",
  "briefTitle": "Yersinia Pestis Lateral Flow Immunoassay for Blood Samples",
  "officialTitle": "Point of Care Diagnostic to Identify the Causative Agent of the Plague in Blood Samples",
  "protocolDocument": {
    "nctId": "NCT04688996",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2020-08-19",
    "uploadDate": "2021-01-19T13:23",
    "size": 918207,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04688996/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 500,
    "enrollmentType": "ESTIMATED"
  },
  "timeline": {
    "startDate": "2020-10-19",
    "completionDate": "2023-01",
    "primaryCompletionDate": "2022-12",
    "firstSubmitDate": "2020-11-24",
    "firstPostDate": "2020-12-30"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion criteria - Malagasy Participants\n\n1. Adults 18 to 75 years old (male and female): Able to receive and give verbal communication.\n2. Children 5 to 17 years old (vulnerable population): Parents or legal guardian must be available to give permission. Parents or legal guardian to consent for children (5-6 years).\n3. Suspected human plague case by local medical professional. Include at least one of the following: For bubonic plague: high fever, chills, and/or presence of painful bubo; For pneumonic plague: high fever, chills, cough for less than 5 days, bloody sputum, and/or chest pains; patients may be recruited from both plague surveillance program and non-plague surveillance programs.\n\nExclusion criteria - Malagasy Participants\n\n1. Children under the age of 5 years old\n2. Children between the age of 5 years to 17 years without a parent or legal guardian\n3. Not compliant with the study procedure (blood sampling)\n\nInclusion criteria - USN Health Center Participants\n\n1. Active duty personnel and DoD beneficiaries that present to participating study sites with influenza-like-illness (fever, cough, sore throat).\n2. Age range \\>=13 to 75 y.o.\n3. Able to receive/give consent (or assent if \\<18 y.o.) 4, Presenting with influenza-like-illness (fever of 100.5 F or higher, cough and/or sore throat)\n\n5\\. USN Special Categories: Minors/children (45CFR Subpt. D/DoDI 3216.02, Encl 3, Para 7d); Students; Active duty military personnel (3216.02, Encl.3 Para. 7.e); Economically disadvantaged persons (32CFR 219.11(b); Educationally disadvantaged persons (32CFR 219.11(b).\n\nExclusion criteria - USN Health Center Participants\n\n1. \\<13 y.o.\n2. Unable to give written consent (if under 18)",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "5 Years",
    "maximumAge": "75 Years",
    "stdAges": [
      "CHILD",
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "LFI results on finger-prick blood correlate with the results of standard WHO-approved diagnostic tests for plague",
        "description": "Description: Standard WHO-approved diagnostic testing uses bubo aspirates or sputum as clinical matrices to perform the following tests: F1RDT, qPCR analysis, and culture.\n\nWHO defines a confirmatory positive plague case when the bubo or sputum is positive on F1RDT and positive on either qPCR or culture.",
        "timeFrame": "Up to 3 weeks post sample collection and processing of each participant."
      }
    ],
    "secondary": [
      {
        "measure": "LFI results on finger-prick blood correlate with LFI results from bubo aspirate or sputum clinical matrices.",
        "description": "Standard WHO-approved diagnostic testing uses bubo aspirates or sputum as clinical matrices to perform the following tests: F1RDT, qPCR analysis, and culture.\n\nWHO defines a confirmatory positive plague case when the bubo or sputum is positive on F1RDT and positive on either qPCR or culture.",
        "timeFrame": "Up to 3 weeks post sample collection and processing of each participant."
      }
    ],
    "other": [
      {
        "measure": "LFI results on finger-prick blood correlate with the test results on venous blood using the following diagnostic methods: LFI, qPCR, ELISA and FilmArray Warrior Panel.",
        "description": "Standard WHO-approved diagnostic testing uses bubo aspirates or sputum as clinical matrices to perform the following tests: F1RDT, qPCR analysis, and culture.\n\nWHO defines a confirmatory positive plague case when the venous blood, bubo or sputum is positive on F1RDT and positive on either qPCR or culture.",
        "timeFrame": "Two years through sample collection and analysis completion from 05/2020 to 05/2022."
      }
    ]
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 1,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 36,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:29.815Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}